Byline Bancorp Inc
NYSE:BY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Byline Bancorp Inc
NYSE:BY
|
US |
|
Genmab A/S
CSE:GMAB
|
DK |
|
Mirae Asset Securities Co Ltd
KRX:006800
|
KR |
|
Bayerische Motoren Werke AG
XETRA:BMW
|
DE |
|
Avalonbay Communities Inc
NYSE:AVB
|
US |
|
Minerals 260 Ltd
ASX:MI6
|
AU |
|
B
|
Brainstorm Cell Therapeutics Inc
XBER:GHDN
|
US |
|
Spectral Medical Inc
TSX:EDT
|
CA |
Wall St Price Targets
BY Price Targets Summary
Byline Bancorp Inc
According to Wall Street analysts, the average 1-year price target for BY is 38.15 USD with a low forecast of 34.34 USD and a high forecast of 42 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BY's stock price target?
Price Target
38.15
USD
According to Wall Street analysts, the average 1-year price target for BY is 38.15 USD with a low forecast of 34.34 USD and a high forecast of 42 USD.
What is the Revenue forecast for Byline Bancorp Inc?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 5%.
What is the Net Income forecast for Byline Bancorp Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 2 years is 9%.
